New Jersey-based GRM Information Management has recently launched its new Safety Station Compliance solution for one of its largest clients; a leading New York-based...
The U.S. Food and Drug Administration conditionally approved Varenzin-CA1 (molidustat oral suspension), the first drug for the control of nonregenerative anemia associated with chronic...
ConcertAI's TeraRecon, the advanced visualization and clinical AI SaaS category leader, has announced the release of its AI-driven clinical suite, Neuro Suite. Purpose-built for...
Medtronic plc , a global leader in healthcare technology, announced it has received U.S. Food and Drug Administration (FDA) approval of its Micra AV2...
